Shree Pushkar Chemicals & Fertilizers Ltd

- The company currently has no immediate pressure to raise funds through debt. - The management aims to avoid taking on any debt and is confident there will be no need for debt financing, with a 99.9999% assurance. - Capital expenditure of around INR 200 crores is being funded mostly through internal accruals and existing investments (INR 140 crores non-lien investments plus INR 70 crores already invested). - The company has a strong liquidity position with INR 141 crores in non-lien deposits. - No mention was made of any planned equity fundraising. - Overall, the strategy is to rely on internal funds and avoid external borrowing in the near future.

- Ongoing capital expenditure projects support growth by expanding production capacity in Chemicals and Fertilizers divisions. - Total capex as of September 30, 2024, stands at approximately INR 68.48 crores, funded through internal accruals. - Planned total capex is around INR 200-225 crores, with INR 70 crores already invested and INR 140 crores in non-lien investments. - Unit 5 capex trial production expected around December-January, with commercial production from March 2025. - Unit 6 capex planned to start trials by Q2 FY26 (July-September 2025), with slight delays acceptable. - Investment targets improved operational efficiencies, cost savings (e.g., solar power reducing electricity costs by 50-60%), and capacity expansion. - The company aims to avoid debt for these investments, relying mainly on internal resources. - Strategic investments also include enhancing product offerings and forward/backward integration for sustainable growth.

- For FY25, revenue is projected around INR 800 to 825 crores with a PAT of approximately INR 60 crores. - For FY26, expected revenue is INR 900 to 1000 crores with PAT margin improving to around 8.5% to 9%. - For FY26-27, revenue target is around INR 1,400 crores plus or minus 5%. - Volume growth in Chemicals: 4.8% YoY in H1 FY25; Fertilizers volume increased 23.6% YoY for H1 FY25. - Current capacity utilization is about 65%, with a potential 5-10% improvement room. - Ongoing capex of INR ~200 crores aimed to enhance capacity without debt, supporting future volume and revenue growth. - Expect gradual EBITDA margin improvement back toward historical 14-15% levels over next 1-2 quarters. - Inventory management strategy is aligned with expected pricing improvements, reflecting confidence in future demand.

- Revenue is expected to grow from INR800-825 crores in FY25 to around INR1,000 crores (+/- 5%) in FY26, and further to INR1,400 crores (+/- 5%) in FY27. - PAT for FY25 is projected around INR60 crores (+/- 5%), with an expected improvement to 8.5%-9% margin in FY26. - EBITDA margins, previously at 14%-15%, are currently resting but expected to recover in the next 1-2 quarters. - Asset turnover for the ongoing INR200 crore capex is estimated at 2 to 2.25 times. - Management anticipates better profitability and margins in coming years, aiming to return to earlier EBITDA (15%) and PAT (around 10%) levels over time. - Conservative outlook highlights steady improvement rather than miraculous jumps, with better pricing and operational efficiencies driving growth. - EPS is expected to improve alongside PAT growth but specific numbers were not disclosed.

- As of November 13, 2024, Shree Pushkar Chemicals & Fertilisers Limited reports a strong order book position. - Orders are secured up to January, indicating a well-packed order pipeline. - The company does not face any significant cash flow pressure and is strategically managing inventory to optimize pricing. - This stable order flow supports their guidance of achieving INR800-825 crores revenue for FY25, with an expected growth to around INR1,000 crores in FY26. - The positive demand outlook and government measures boosting industrial production underline confidence in sustained orders.